- The current clinical trials, led by Dr. Luis Ignacio Casanova of the hospital's Neurology Department, are focused on slowing the progression of the disease with new drugs.
- The research activity promoted by the group brings innovative therapies to patients in areas such as Neurology, but also in Gynecology and Oncology.
Clinical research is one of the strategic pillars of the healthcare group Riberawhich, through its hospitals, promotes the development of clinical trials, observational studies, and projects aimed at improving the management of complex diseases such as multiple sclerosis. In this context, the Torrejón University Hospital, which stands out for its important research activity, develops cutting-edge clinical trials in the field of Neurology focused on improving the treatment of this chronic pathology of the central nervous system.
“Multiple sclerosis is a complex disease about which many aspects are still unknown and in which there is much room for improvement,” says Dr. Luis Ignacio Casanova, from the Neurology Department at Torrejón Hospital. This healthcare center is currently participating in clinical trials aimed at developing new treatments to halt the progression of the disease beyond relapses, one of the main challenges in its management.
“The trials we are participating in seek to develop drugs capable of slowing the slow progression of the disease, in line with international research on neuroprotection and neuroregeneration,” explains the specialist.
Research that improves patient care
Investing in research allows innovation to be translated into clinical practice and improves patient care. “Opening research lines within the Torrejón hospital allows our patients to access innovative therapies, offers more up-to-date care, and improves the overall quality of service,” emphasizes Dr. Casanova.
Furthermore, the research promotes multidisciplinary work and collaboration between professionals and specialties, reinforcing the Ribera group's care model.
A model based on specialization, assistance, and innovation
The Neurology Department at Torrejón University Hospital combines clinical experience, specialization, and research to offer personalized care. “The combination of these factors allows us to offer more accurate diagnoses, tailored treatments, and closer follow-up, while also incorporating innovative tools,” says the specialist.
Multiple sclerosis can affect mobility, vision, balance, or cognitive ability, and has a significant impact on patients' lives, especially considering that it is usually diagnosed in young people.
Advances that open new opportunities
Thanks to research conducted in recent years, including by the Torrejón Hospital, the approach to multiple sclerosis has changed significantly. “Today we have treatments that didn't exist before and that have radically changed the way the disease is managed and the quality of life for patients,” emphasizes Dr. Casanova.
“We are at a hopeful moment, with constant progress toward more effective, safe, and personalized treatments. Today, multiple sclerosis can be treated and managed much better than years ago. Early diagnosis, personalized follow-up, and advances in research are changing the course of the disease. Patients are not alone,” he concludes.
